Related Experiment Video
Updated: Jun 4, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Trends in the survival of very preterm infants between 2011 and 2020 in France
Victoria Butler1,2, Luc Gaulard3, Victor Sartorius3,4
1Centre for Research in Epidemiology and Statistics Obstetrical Perinatal and Pediatric Epidemiology Research Team, Paris, Île-de-France, France victoria.butler@aphp.fr.
Insights
Survival rates for very preterm infants (less than 32 weeks gestational age) improved significantly in France between 2011 and 2020, especially for those born at 23 and 24 weeks. These findings highlight advancements in neonatal care for extremely premature babies.
Area of Science:
- Neonatalogy
- Perinatal Epidemiology
- Public Health
Background:
- The EPIPAGE-2 cohort provided initial data on very preterm infants in 2011.
- National-level data on very preterm infant survival are crucial for assessing healthcare quality.
- Evaluating survival trends helps identify areas for improved neonatal care.
Purpose of the Study:
- To assess changes in survival to discharge for liveborn infants under 32 weeks gestational age in France.
- To compare very preterm infant survival rates across 2011, 2015, and 2020.
- To identify specific gestational age ranges showing significant survival improvements.
Main Methods:
- Population-based cohort study utilizing EPIPAGE-2 data (2011) and national health data (2015, 2020).
- Inclusion of all births between 22 and 31 weeks gestational age.
- Primary outcome: survival to hospital discharge, analyzed using modified Poisson regression with adjustments for covariates.
Main Results:
- Survival to discharge significantly increased for infants born at 23 and 24 weeks gestational age between 2011 and 2020.
- Survival rates showed a trend of increase from 25 to 28 weeks gestational age, though not statistically significant.
- Survival remained stable for infants between 29 and 31 weeks gestational age.
- The proportion of live births increased for gestational ages 22-24 weeks.
Conclusions:
- Neonatal survival rates for liveborn infants improved between 23 and 28 weeks gestational age from 2011 to 2020.
- The most substantial improvements were observed at the earliest gestations (23-24 weeks).
- These findings indicate progress in the management and care of very preterm infants in France.
Objective:
The objective is to evaluate changes in survival to discharge of liveborn infants less than 32 weeks' gestational age (GA) in France, where the latest available data on very preterm survival at a national-level are from the EPIPAGE-2 (Etude épidémiologique sur les petits âges gestationnels) cohort in 2011.
Design:
Population-based cohort study.
Setting:
Metropolitan France in 2011, 2015 and 2020.
Patients:
All births between 22 and 31 weeks' GA using the EPIPAGE-2 cohort study for the year 2011 and hospital discharge data linked to death certificates from the Système National des Données de Santé for the years 2015 and 2020.
Main Outcome Measures:
The primary outcome was survival to hospital discharge among liveborn infants. Survival rates were compared using modified Poisson regression and adjusted for population characteristics (maternal age, multiple birth, sex, small for GA). Data on all births were examined to assess changes to the live birth rate.
Results:
Survival to discharge among live births increased at 23 and 24 weeks' GA from 1% and 31% in 2011 to 8% and 37% in 2015 and to 31% and 47% in 2020, respectively. From 25 to 28 weeks' GA, survival rates tended to increase, but differences were not significant, and survival rates were stable from 29 to 31 weeks GA. Results were similar after adjustment. The proportion of live births versus stillbirths increased from 22 to 24 weeks' GA.
Conclusion:
Survival rates among live births improved between 2011 and 2020 from 23 to 28 weeks' GA, with marked changes at 23 and 24 weeks' GA.
Related Concept Videos
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Cancer Survival Analysis
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...

